Bioactive glasses and glass/polymer composites for neuroregeneration: Should we be hopeful? by Kargozar, S. et al.
04 August 2020
POLITECNICO DI TORINO
Repository ISTITUZIONALE
Bioactive glasses and glass/polymer composites for neuroregeneration: Should we be hopeful? / Kargozar, S.; Mozafari,
M.; Ghenaatgar-Kasbi, M.; Baino, F.. - In: APPLIED SCIENCES. - ISSN 2076-3417. - ELETTRONICO. - 10:10(2020), p.
3421.
Original
Bioactive glasses and glass/polymer composites for neuroregeneration: Should we be hopeful?
Publisher:
Published
DOI:10.3390/app10103421
Terms of use:
openAccess
Publisher copyright
(Article begins on next page)
This article is made available under terms and conditions as specified in the  corresponding bibliographic description in
the repository
Availability:
This version is available at: 11583/2837394 since: 2020-06-25T18:04:30Z
MDPI AG
applied  
sciences
Review
Bioactive Glasses and Glass/Polymer Composites for
Neuroregeneration: Should We Be Hopeful?
Saeid Kargozar 1,* , Masoud Mozafari 2 , Maryam Ghenaatgar-Kasbi 3 and
Francesco Baino 4,*
1 Tissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine,
Mashhad University of Medical Sciences, Mashhad 917794-8564, Iran
2 Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine,
Iran University of Medical Sciences (IUMS), Tehran 1449614535, Iran; mozafari.masoud@gmail.com
3 Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences,
Mashhad 917794-8564, Iran; Ghenaatgar.maryam@gmail.com
4 Institute of Materials Physics and Engineering, Applied Science and Technology Department,
Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
* Correspondence: kargozarsaeid@gmail.com (S.K.); francesco.baino@polito.it (F.B.);
Tel.: +98-513-800-2539 (S.K.); +39-011-090-4668 (F.B.)
Received: 14 April 2020; Accepted: 12 May 2020; Published: 15 May 2020


Abstract: Bioactive glasses (BGs) have been identified as highly versatile materials in tissue engineering
applications; apart from being used for bone repair for many years, they have recently shown promise
for the regeneration of peripheral nerves as well. They can be formulated in different shapes and
forms (micro-/nanoparticles, micro-/nanofibers, and tubes), thus potentially meeting the diverse
requirements for neuroregeneration. Mechanical and biological improvements in three-dimensional
(3D) polymeric scaffolds could be easily provided by adding BGs to their composition. Various types
of silicate, borate, and phosphate BGs have been examined for use in neuroregeneration. In general,
BGs show good compatibility with the nervous system compartments both in vitro and in vivo.
Functionalization and surface modification plus doping with therapeutic ions make BGs even more
effective in peripheral nerve regeneration. Moreover, the combination of BGs with conductive
polymers is suggested to improve neural cell functions at injured sites. Taking advantage of BGs
combined with novel technologies in tissue engineering, like 3D printing, can open new horizons in
reconstructive approaches for the nervous system. Although there are great potential opportunities
in BG-based therapies for peripheral nerve regeneration, more research should still be performed to
carefully assess the pros and cons of BGs in neuroregeneration strategies.
Keywords: biomaterials; bioactive glasses; polymers; composites; nanomaterials; peripheral nerve
regeneration; tissue engineering
1. Introduction
The nervous system is vital in the human body and is made from two distinct components,
the central nervous system (CNS) and the peripheral nervous system (PNS). Both parts are potentially
subjected to various acute and chronic diseases and injuries, causing reduced quality of life [1–3].
In the case of peripheral nerve injuries, mechanical stress; exposure to heat, cold, and irradiation;
tumors; and focal inflammation are the main reasons for partial or total loss of motor, sensory,
and autonomic functions [4]. For example, cutting of the nerve as a result of traumatic injuries may
result in complications like inability to move muscles, dysfunctional or no feeling of normal sensations,
and eventually painful neuropathies [5]. To date, huge numbers of experimental studies have been
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conducted to provide appropriate substitutes for the reconstruction of lost/injured peripheral nerves.
Autografts, mostly harvested from the sural nerve, are still identified as the gold standard for the
regeneration of nerves as regards lack of rejection and providing a proper biological environment for
axon reconstruction [6]. Another approach for restoring segmental nerve injuries involves the use of
allografts, which depends on the viability of host and donor Schwann cells since they are responsible
for the proper re-myelination process and serve as the main source for neurotrophic factors [7–9]. In the
era of tissue engineering and regenerative medicine, the use of natural and synthetic biopolymers
offers notable opportunities in neuroregeneration approaches [10–12]. Furthermore, scientists are
steadily applying engineering approaches for the modification and improvement of polymeric tissue
substitutes to accelerate neural tissue repair and regeneration. In this context, the use of bioactive
glasses (BGs) for neural tissue engineering is emerging as an innovative strategy.
BGs have been conventionally applied for the repair and regeneration of osseous tissue in
orthopedic and dental applications due to their capability of forming a chemical bond with living
bone [13]. This unique property relies on an ion-exchange mechanism between glass and biological
fluids, leading to the formation of an interfacial layer of nano-hydroxyapatite. The fundamentals of
BG processing, properties, and applications in contact with bone have been comprehensively reviewed
elsewhere [14–16].
Furthermore, it can be stated that there is a consensus among the experts in the field on the
suitability of BGs for soft tissue engineering applications, too. Several studies have shown and
summarized the use of different types of glasses in the management of soft-tissue-related damage and
injuries [17,18]. Peripheral nerve and spinal cord regeneration have also been amongst the targets of
BG-based therapies [19]. Many relevant studies have proposed the use of silicate-based BGs for nerve
regeneration [20,21]; however, these materials often suffer from mechanical fragility and brittleness and,
even more importantly, lack of degradability in biological environments, which hinders their application
as effective tissue-engineered implantable temporary device [22]. Therefore, other types of BGs, i.e.,
phosphate- and borate-based glasses, were applied as alternatives in neuroregeneration strategies
to overcome the limitations of silicate-based BGs [23,24]. In this regard, glasses in different shapes
(particles and fibers) were added to polymeric matrixes to fabricate three-dimensional (3D) composite
scaffolds which are flexible substitutes for neural tissue engineering [24,25]. Despite the promising
early results, there are many substantial questions that should be addressed before the extensive
usage of BGs, including the toxicity of BG by-products in the defect sites. Furthermore, tuning the
degradation time of BGs should be carefully assessed as it may affect the final clinical outcome.
Even more importantly, the electrical insulation feature of these glasses seems a big drawback as prior
studies showed that electrical stimulation enhances functional nerve regeneration [26,27].
In this review article, we discuss the results of studies dealing with the application of BGs in nerve
tissue engineering, emphasizing the latest advances, and try to draw an outline for future research
in the field. As most of the studies are related to the regeneration of peripheral nerves by using BGs,
this work mainly focuses on their potential in the management of relevant injuries and damage.
2. The Structure of Peripheral Nerves—Looking at What We Want to Regenerate
The nervous system in the human being is generally divided into the CNS and PNS,
controlling voluntary and involuntary activities of the human body such as skeletal muscle
contractions [28]. The CNS is composed of the brain and spinal cord containing interneurons, while the
PNS includes peripheral cranial and spinal nerves with sensory and motor neurons [29]. The peripheral
cranial and spinal nerves originate from the brainstem and the dorsal or ventral roots of the spinal
cord, respectively (see Figure 1). Sensory axons are placed in dorsal roots and carry signals into the
CNS, while motor axons are found in ventral roots and carry signals from CNS-originating neurons to
muscles and glands [30].
Appl. Sci. 2020, 10, 3421 3 of 20
Appl. Sci. 2020, 10, x FOR PEER REVIEW 3 of 20 
 
Figure 1. Schematic representation of a peripheral spinal nerve (cross-sectional view) showing its 
layers and components. Reproduced with permission from ref [31]. 
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sending signals to other cells and tissues. Transfer of the electrical signals is conducted via neuron 
extensions, i.e., axons and dendrites. A peripheral nerve contains both dendrites and axons in its 
structure [32]. Histologically, peripheral nerves are complex tissues which are composed of 
parenchyma (Schwann cells and axons) and a stroma (a “natural scaffold” made of connective tissue 
elements) [33]. The nerve fibers are the smallest functional units of a peripheral nerve and can be 
categorized as myelinated or unmyelinated depending on the presence of Schwann cells. They are 
responsible for conducting information to (afferent) or from (efferent) the CNS. Due to their extension 
in the body, peripheral nerves are exposed to a broad range of diseases and injuries, such as 
neuropraxia, axonotmesis, neural mutilation, and nerve defects [34,35]. For instance, accidental 
trauma may result in physical and sensory malfunctions of the extremities and cause loss of 
movement and loss of skeletal muscle mass (muscle atrophy) [36]. Suturing nerve stumps together is 
commonly used for managing small defects, while the implantation of a substitute is necessary to 
make a bridge between the broken ends and support naturally regenerating axons to the distal 
segment. Most in vivo studies focused on peripheral nerve regeneration have been conducted in 
animal models of the sciatic nerve in the hindlimb; however, reconstruction of cranial nerves is of 
great importance, too, as their injuries might lead to permanent facial disfigurement [37]. 
3. Post-Injury Scenario—A Short Overview 
Following the cutting of a nerve (axotomy), a series of molecular and cellular mechanisms, 
including the activation of cell survival pathways and up-regulation of regeneration-associated 
genes, happen in temporal and spatial coordination to encourage peripheral nerve regeneration in 
the injured site [38]. The main signaling pathways involved in peripheral nerve regeneration include 
phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB or Akt) (PI3K/Akt) signaling (increasing 
survival, growth, and differentiation of cells), Ras–mitogen-activated protein kinase (Ras/MAPK) 
signaling (enhancing neurite outgrowth and Schwann cell differentiation and myelination), cyclic 
AMP (cAMP) signaling (improving guidance, differentiation, neurite outgrowth, and neuronal 
survival), and Rho/Rho-associated coiled-coil containing protein kinase (Rho/ROCK) signaling 
(modulating neurite outgrowth) [39,40]. Moreover, some studies emphasize the critical role of 
angiogenic signaling pathways in improving the quality of peripheral nerve repair [41]. 
Experimental evidence suggests that all these biomolecular events may result in axon 
regeneration at a rate of 1–3 mm/day, which significantly reduces with increasing time and distance 
Figure 1. Schematic representation of a peripheral spinal nerve (cross-sectional view) showing its
layers and components. Reproduced with permission from ref [31].
Neurons are specialized cells of the nervous system serving as compartments for receiving and
sending signals to other cells and tissues. Transfer of the electrical signals is conducted via neuron
extensions, i.e., axons and dendrites. A peripheral nerve contains both dendrites and axons in its
structure [32]. Histologically, peripheral nerves are complex tissues which are composed of parenchyma
(Schwann cells and axons) and a stroma (a “natural scaffold” made of connective tissue elements) [33].
The nerve fibers are the smallest functional units of a peripheral nerve and can be categorized as
myelinated or unmyelinated depending on the presence of Schwann cells. They are responsible
for conducting information to (afferent) or from (efferent) the CNS. Due to their extension in the
body, peripheral nerves are exposed to a broad range of diseases and injuries, such as neuropraxia,
axonotmesis, neural mutilation, and nerve defects [34,35]. For instance, accidental trauma may result
in physical and sensory malfunctions of the extremities and cause loss of movement and loss of skeletal
muscle mass (muscle atrophy) [36]. Suturing nerve stumps together is commonly used for managing
small defects, while the implantation of a substitute is necessary to make a bridge between the broken
ends and support naturally regenerating axons to the distal segment. Most in vivo studies focused
on peripheral nerve regeneration have been conducted in animal models of the sciatic nerve in the
hindlimb; however, reconstruction of cranial nerves is of great importance, too, as their injuries might
lead to permanent facial disfigurement [37].
3. Post-Injury Scenario—A Short Overview
Following the cutting of a nerve (axotomy), a series of molecular and cellular mechanisms,
including the activation of cell survival pathways and up-regulation of regeneration-associated genes,
happen in temporal and spatial coordination to encourage peripheral nerve regeneration in the
injured site [38]. The main signaling pathways involved in peripheral nerve regeneration include
phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB or Akt) (PI3K/Akt) signaling (increasing
survival, growth, and differentiation of cells), Ras–mitogen-activated protein kinase (Ras/MAPK)
signaling (enhancing neurite outgrowth and Schwann cell differentiation and myelination), cyclic AMP
(cAMP) signaling (improving guidance, differentiation, neurite outgrowth, and neuronal survival),
and Rho/Rho-associated coiled-coil containing protein kinase (Rho/ROCK) signaling (modulating
neurite outgrowth) [39,40]. Moreover, some studies emphasize the critical role of angiogenic signaling
pathways in improving the quality of peripheral nerve repair [41].
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Experimental evidence suggests that all these biomolecular events may result in axon regeneration
at a rate of 1–3 mm/day, which significantly reduces with increasing time and distance from
injury [42–44]. Therefore, peripheral nerves have no adequate regenerative capacity to rebuild their
structure and function after severe injuries causing nerve gaps longer than 2 cm [45]. The use of
autografts and allografts has a long history in the repair and regeneration of peripheral nerves;
however, there are limitations in case of their extensive usage, including the shortage of donors,
immune rejection, and the transfer of pathogens [46–48]. With the advent of the tissue engineering
concept, polymers have achieved great success in peripheral nerve regeneration; however, other types of
materials (ceramics and glasses) have also been examined for accelerating the healing process [23,49–51].
Specifically, bioactive materials could be applied alone or in combination with polymers; constructs
containing cells (e.g., mesenchymal stem cells) and growth factors (e.g., vascular endothelial growth
factor (VEGF)) facilitate the restoration of nerve structure and function via distinct approaches such as
increased cell growth, improved angiogenesis, and providing tissue attachment possibilities in either
bare or modified types [52–55]. Moreover, the use of materials capable of reducing inflammation and
oxidative stress, such as nanoceria, gives further added value to peripheral nerve injury strategies [56,57].
The applicability of different types of BGs, including silicate-, phosphate-, and borosilicate-based
glasses, has been assessed through a series of experimental studies [58–61]. To date, various forms and
shapes of BGs have been produced and assessed in vitro and in vivo for nerve repair and regeneration,
including glass tubes, glass powder/polymer tubes, and glass fiber/polymer warps. The concept behind
the use of BGs in neuroregeneration relies on their ability to (1) improve cell growth and proliferation,
(2) promote angiogenesis, (3) reduce inflammation, and (4) increase mechanical strength [23,62–66].
4. Silicate-Based BGs in Peripheral Nerve Regeneration
Looking at the literature, silicate glasses were apparently the first type of BGs to be proposed in
the management of peripheral nerve injuries (Table 1). In 2005, Bunting et al. prepared Bioglass®
45S5 fibers (10 mm diameter) and entubulated them within silastic conduits to fabricate scaffolds with
the ability to guide the re-growth of peripheral axons of adult rats [60]. The constructs were successfully
implanted and allowed axonal regrowth in the animal model; specifically, the postoperative outcome
was considered comparable with that obtained by using an autograft. Over time, ion-doped silicate
glasses were also investigated as effective materials for accelerating peripheral nerve regeneration [67].
For instance, SiO2–Na2O–CaO–ZnO–CeO2 glasses have been suggested as suitable materials for the
repair of peripheral nerve discontinuities due to the beneficial release of Ca2+ (19.26–3130 ppm) and
Zn2+ (5.97–4904 ppm) ions stimulating cells towards regenerative pathways [59]. In 2014, the usability
of a composite made of 45S5 glass nanoparticles and gelatin was evaluated for peripheral nerve
regeneration [20]. The sol–gel glass particles were added to the gelatin matrix, and their interfacial
bonding interaction was approved in the developed conduits. The in vitro data showed the positive
effects of the composite conduits on cell viability, and in vivo implantation of the samples in the sciatic
nerve of a male rat resulted in proper nerve regeneration (structurally and functionally) comparable to
that of control groups three months after surgery (see Figure 2).
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implantation and (b2), (b3), and (b4) represent the conduits at 30, 60, and 90 days post-implantation. 
(C) Histological longitudinal section of the implanted conduits at 30 (a), 60 (b), and 90 (c) days post-
surgery, confirming the nerve outgrowth from proximal (P, right) to distal (D, left) (×10). Reproduced 
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Figure 2. (A) SEM micrographs of the nano 45S5 Bioglass/gelatin conduits; cross-sectional view of the
composites (200×) (a), outer layer of the conduit wall (500×) (b), and its inner layer (300×) (c). (B) The
illustration (a1) shows the implantation process of nerve conduits made of 45S5 nano-Bioglass/gelatin
into a 10 mm long gap defect in the sciatic nerve in rats and (a2) and a macroscopic image of the
regenerated nerve at 3 months post-surgery. (b1) shows nano Bioglass/gelatin conduits prior to the
implantation and (b2), (b3), and (b4) represent the conduits at 30, 60, and 90 days post-implantation.
(C) Histological longitudinal section of the implanted conduits at 30 (a), 60 (b), and 90 (c) days
post-surgery, confirming the nerve outgrowth from proximal (p, right) to distal (d, left) (×10).
Reproduced with permission from ref [20].
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More recently, electrospun films made of polypyrrole/collagen polymers and strontium-substituted
nano-sized BGs (PPY/Coll/n-Sr@BG) were evaluated for the promotion of sciatic nerve rejuvenation
in vivo [68]. These constructs demonstrated a native-mimicking morphology, better porosity, and higher
specific surface area than customary nerve channels, thus allowing appropriate transportation of nerve
development factor and glucose, as well as hindering the section of lymphatic tissue and fibroblasts.
Furthermore, PPY/Coll/n-Sr@BG provided a suitable substrate for the growth and expansion of
neurilemma cells. PPY/Coll/n-Sr@BG resulted in viable recovery of sciatic nerve wounds at 24 weeks
post-implantation in rats which was comparable to the results of autotransplants and superior to those
of PPY/Coll groups.
Electrospun composites based on poly(glycolic acid) (PGA)/collagen/nano-sized BG (NBG)
were fabricated as potential nerve conduits by Dehnavi et al. [69]. The obtained data proved the
superior features of NBG-containing nanofibrous conduits in comparison to glass-free counterparts
(PGA or PGA/collagen groups) in terms of mechanical/chemical properties, biocompatibility,
and biodegradability.
Silicate-based BGs have also been applied in other shapes, including aligned microfibers.
Souza et al. fabricated double-layered conduits by the incorporation of BG microfibers
(SiO2–Na2O–K2O–MgO–CaO–P2O5 system) in nanofibrous poly(ε-caprolactone) (PCL) membranes [70].
The PCL polymer was electrospun upon BG microfibers (20± 2.3µm) to make a two-layer bio-composite.
The fabricated samples were permeable to water vapor, thus facilitating the exchange of cell metabolites
between the inner portion of the nerve guide and the surrounding environment. In addition, a significant
decrease in contact angle and an increase in mechanical properties were recorded as a result of the
incorporation of BG fibers into the electrospun polymeric scaffolds.
5. Phosphate-Based BGs in Peripheral Nerve Regeneration
Although most studies involving phosphate-based BGs have addressed hard tissue
engineering [71–75], there is recent evidence supporting the suitability of this kind of glass in peripheral
nerve regeneration, too (Table 1). In fact, phosphate glass fibers were shown to play an effective role
in promoting neurite outgrowth in vitro and peripheral nerve regeneration in vivo [24]. Kim et al.
synthesized 50P2O5-40CaO-5Na2O-5Fe2O3 (mol.%) phosphate BG fibers (14.99 ± 2.77 µm in diameter)
by using a melt-spinning method and successfully aligned the fibers on a compressed collagen matrix
while rolling them into a nerve conduit. These composite tubular scaffolds showed positive effects on
the outgrowth of adult dorsal root ganglion (DRG) neurons in vitro. Moreover, the authors observed
the ability of the scaffolds to allow axon extension and the recovery of plantar muscle atrophy at 1 and
8 weeks post-implantation in transected sciatic nerves of rats. However, no significant differences were
recorded between the BG-containing scaffolds and their glass-free counterparts regarding the number
of axons, muscle atrophy, or motor and sensory functions 12 weeks after implantation (see Figure 3).
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µm). Cross-sectional images 1 mm distal from (h) the collagen group and (i) the PGf/collagen group 
at 8 weeks post-implantation, and (j) the collagen group and (k) the PGf/collagen group after 12 
weeks. (l) shows the number of axons at 1 mm distal to the scaffolds 8 and 12 weeks post-implantation. 
DIC: differential interference contrast microscope. DAPI: 4′,6-diamidino-2-phenylindole. Reproduced 
with permission from ref [24]. 
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was 50P2O5–40CaO–5Na2O–5Fe2O3 (mol.%), and aligned fibers with a diameter of 18.49 ± 4.74 µm 
were produced to examine the healing properties. High levels of calcium and iron in the glass 
resulted in less soluble fibers to better support neuronal growth. The prepared constructs were 
implanted into completely transected rat spinal cords, and the outcomes were compared with those 
i r 3. ff fi ( c ll ( l) i f
eri eral erve regeneration: ( ) ( ) t t t f t i f t ff l s
t ir s i icr sco y (S ) photographs (scale bar = ). ( ), ( ), ( ) s t s r r
r c r r l t t co plete transection of the sciatic nerve, the implantati n of the composites
(0.8 mm diameter, 3 mm long), and suturing of the neural s eath with 10-0 nylon suture, respectively.
(B) Illustration of immunohistological staining of animal axons within the (a) cross-section of an intact
sciatic nerve; (b) cross-section of the scaffold collagen group; and (c) P f/collagen scaffolds at 7 days
post-surgery. (d) and (e) exhibit agnified i ages of the yello boxes in (c). (f) and (g) represent
high- agnification images of the white boxes in (c) (white scale bar = 200 µm, yellow scale bar = 20 µm).
Cross-sectional images 1 mm distal from (h) the collagen group and (i) the PGf/collagen group at 8 weeks
post-implantation, and (j) the collagen group and (k) the PGf/collagen group after 12 weeks. (l) shows
the number of axons at 1 mm distal to the scaffolds 8 and 12 weeks post-implantation. DIC: differential
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from ref [24].
Full regeneration of a spinal cord injury is one of the ultimate targets in neuroregenerative
medicine strategies. To this end, 3D composite hydrogel scaffolds made of phosphate BG and collagen
were evaluated in a rodent model of transected rat spinal cord [76]. The glass formulation was
50P2O5–40CaO–5Na2O–5Fe2O3 (mol.%), and aligned fibers with a diameter of 18.49 ± 4.74 µm were
produced to examine the healing properties. High levels of calcium and iron in the glass resulted
in less soluble fibers to better support neuronal growth. The prepared constructs were implanted
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into completely transected rat spinal cords, and the outcomes were compared with those of glass-free
collagen scaffolds. The obtained results revealed axon growth from the proximal and distal stumps
to the glass-containing scaffolds after 12 postoperative weeks due to the directional guidance for
outgrowing axons (Figure 4). Additionally, an improvement in locomotion ability was observed in the
experimental groups receiving the glass-containing implant as compared to the controls after 12 weeks
of implantation. At the same time, the mRNA levels of brain-derived neurotrophic factor (BDNF) in
the bladder of rats were increased more in the glass-containing hydrogel scaffolds than in the control.
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Figure 4. (A) Representation of (a) SEM images of fabricated phosphate glass fibers (PGFs);
(b) PGF–collagen gel complex post dehydration process; (c) and (d) SEM micrograph of the PGF–collagen
scaffold and magnified image of the yellow box in (c), respectively. (B) Images illustrating the surgical
procedure for implantation of the scaffolds into completely transected rat spinal cords (a–e). Reproduced
with some modifications from ref [76].
The use of glass fibers for the reconstruction of injured nerves has been a promising approach in
tissue engineering strategies due to the relatively easy and precise tailoring of the fiber diameter and
shape. As regards these critical issues, Vitale-Brovarone et al. synthesized titanium-containing phosphate
glass fibers in a compositional range of 50P2O5–30CaO–9Na2O–3SiO2–3MgO–(5–x)K2O–xTiO2 mol.%
(x = 0, 2.5, 5) to evaluate the materials’ efficacy in stimulating neuronal polarization and axonal growth
along the fiber direction [77]. The degradation rate of the fibers in vitro was dependent on the glass
composition since increasing TiO2 content decreased the glass solubility. In addition, the fiber diameter
was reported to be another important parameter in the dissolution kinetics. The cellular assessments
showed that aligned configuration of the glass fibers could provide a directional cue for axonal growth
due to the formation of an anisotropic environment (see Figure 5).
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scaffolds significantly improved the outgrowth of neurites of dorsal root ganglia and increased the 
maximal neurite length. In vivo results showed that the implantation of the scaffolds into a 10 mm 
transected sciatic nerve could successfully promote the tissue healing process at 16 postoperative 
Figure 5. (a) Inverted microscope images presenting dorsal root ganglion (DRG) neurons on a glass
coverslip at day 0, showing a rounded morphology; (b) SEM micrographs of DRG neurons at 3 days
post-incubation on glass slices containing 2.5% Ti (mol.%); (c) SEM and (d) confocal microscope
micrographs showing DRG neurons at 3 days post-incubation on glass coverslips. (e) Confocal
microscope images exhibiting DRG neurons at 3 days post-incubation on glass coverslips, showing long
neurites; (f) and (g) DRG neurons on 25 µm glass fibers containing 2.5% Ti (mol.%), presenting long
neurites extended along the fiber axis direction. TiPS2.5: phosphate glasses with composition (mol.%)
50P2O5–30CaO–9Na2O–3SiO2–3MgO–(5 – x)K2O–xTiO2, with x equal to 2.5. Reproduced with
permission from ref [77].
Functionalization and su face modification are considered to be very valuable approaches in order
to improve the inherent properties of BGs for tissue e gineering strategies [78]. In t is context, Ahn et al.
prepared composites of carbon nanotubes (CNTs) interfaced with phosphate BG microfibers for the
regeneration of transected sciatic nerve [79]. For this purpose, the authors chemically bonded aminated
CNTs onto the surface of the aligned glasses and subsequently placed them into 3D poly(L/D-lactic acid)
(PLDLA) tubes. The in vitro data demonstrated that these tubular scaffolds significantly improved the
outgrowth of neurites of dorsal root ganglia and increased the maximal neurite length. In vivo results
showed that the implantation of the scaffolds into a 10 mm transected sciatic nerve could successfully
promote the tissue healing process at 16 postoperative weeks (Figure 6). The authors suggested that
this improvement was due to the grafting of an electrically conductive nanomaterial (i.e., CNTs) to the
BG-containing PLDLA scaffolds.
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Table 1. A summary of currently available reports showing the suitability of different types of BGs and glass-based composites in peripheral nerve repair
and regeneration.
BG Composition/Synthesis Route Applied Construct Remarks Ref (s)
64 SiO2, 26 CaO, 5 MgO and 5 P2O5 (mol%),
sol–gel method
Silicate glass nanoparticles/gelatin
nanocomposites
- The composites showed no significant cytotoxicity
- The composite showed great potential in the regeneration of myelinated
axons in damaged sciatic nerves
[20]
45S5 BG: 45.0 SiO2, 24.5 Na2O, 24.5 CaO,
and 6.0 P2O5 (wt%)
Borate glass: 53 SiO2, 20 CaO, 6 Na2O, 4 P2O5,
12 K2O, 5% MgO (wt%), melt-derived method
Silicate
glass/polyhydroxyalkanoate (PHA)
composites
- The composites exhibited good biocompatibility
- The constructs improved the mechanical properties needed for the
regeneration of peripheral nerves
- The constructs supported growth and neuronal differentiation
[21]
Bioglass 45S5 (45% SiO2, 24% Na2O, 24.5%
CaO and
6% P2O5) (wt%), melt-derived method
Silicate glass (45S5) fibers
- The glass fibers provided a suitable substrate for the adhesion and growth of
rat Schwann cells
- Axonal regeneration occurred through a Silastic conduit filled with
Bioglass fibers
- Axonal regrowth was observed in the Bioglass-fiber-treated rats comparable
to an autograft 4 weeks after implantation in a 0.5 cm interstump gap in the
sciatic nerves
[60]
45S5 BG: 45% SiO2, 24%
Na2O, 24.5% CaO and 6% P2O5 (wt%)
substituted with Zn (5, 10, and 20 wt%)
Silicate glass (45S5) doped with Zn
- Bioglasses doped with low concentration of Zn supported cell adhesion and
proliferation of undifferentiated SK-N-BE human neuroblastoma cells
- Bioglasses doped with high Zn concentration lightly induced adhesion and
phenotype characterization of the cells
[67]
Commercial nano-sized 45S5 BG
Silicate glass
nanoparticles/polyglycolic acid
(PGA), collagen
electrospun composites
- The glass-containing nanofibers showed good compatibility with rats’
mesenchymal stem cells (MSCs)
- The composite constructs provided a better substrate for cell adhesion and
proliferation as compared to glass-free matrixes
[69]
SiO2–Na2O–K2O–MgO–CaO–P2O5
Silicate glass microfibers
incorporated in nanofibrous PCL
- Significant improvements in the mechanical properties and wettability were
observed in the case of glass/polymer composites than the polymer
matrix alone
- The composites showed increased bioactivity
[70]
50 P2O5, 40 CaO,
5 Na2O, 5 Fe2O3 (mol%), melt-derived method
Phosphate glass/collagen scaffolds
- Stimulated neurite outgrowth along the fibers in vitro
- Enhanced axons extending along the scaffold at 7 days post-surgery
- Caused recovery of plantar muscle atrophy at 8 weeks post-implantation
- No significant differences in the case of functional capacity between the
experimental groups and controls (collagen scaffolds lacking BGs) 12 weeks
after implantation
[24]
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Table 1. Cont.
BG Composition/Synthesis Route Applied Construct Remarks Ref (s)
50 P2O5, 40 CaO,
5 Na2O, 5 Fe2O3 (mol%), melt-derived method
Phosphate glass
fiber/collagen scaffolds
- The scaffolds induced axon growth from the proximal and distal stumps to
the scaffold 12 weeks after implantation
- The composites recovered locomotor and bladder functions at
8 weeks post-implantation
- Endogenous BDNF levels were detected in the bladder at
12 weeks post-implantation
[76]
50P2O5–30CaO–9Na2O–3SiO2–3MgO–(5–
x)K2O–xTiO2 mol.% (x = 0, 2.5, 5)
Phosphate glass fibers with a
diameter ranging between
25 and 82 µm
- The glass fibers provided a proper substrate for cell adhesion
and proliferation
- The aligned configuration of the fibers supported the growing axons of
dorsal root ganglion (DRG) neurons along the fiber axis direction
[77]
50P2O5–40CaO–5Na2O–5Fe2O3 (mol.%)
Phosphate glass
microfibers–aminated carbon
nanotubes (CNTs) incorporated
into poly(L/D-lactic acid)
(PLDLA) tubes
- Neurites of DRG outgrew along the aligned composite scaffolds
- The constructs increased the number of regenerating axons and improved the
electrophysiological functions
[79]
13–93 B3 borate glass: 53B2O3, 20 CaO, 6Na2O,
12K2O, 5MgO, 4P2O (wt%)
Borate glass rods and
microfiber/fibrin composites
- Borate glasses and the composite scaffolds improved neurite extension
comparable to that of control fibrin scaffolds, clarifying the lack of significant
effect of the glasses on neuronal health
- Aligned glass scaffolds could guide neurite extension in an oriented manner
[23]
13–93 B3 borate glass;
45S5 silicate glass;
a blend of 13–93 B3 and 45S5 glasses
Borate and silicate
glasses/PCL composites
- The composites containing 13–93 B3 borate glass exhibited a higher
degradation rate than their counterparts containing only 45S5 silicate glass
- None of the glasses caused adverse effects on neurite extension as compared
to PCL alone
- Neurite extension was increased in contact with PCL:45S5 PCL:13–93 B3
composites after 24 h of incubation
[25]
13-93 B3 borate glass doped with Ag, Ce, Cu,
Fe, Ga, iodine (I), Y, and Zn Borate glass/PCL composite sheets
- Cu, Fe, Ga, Zn, and Sr-doped glasses promoted the survival and outgrowth
of neurons as compared to undoped glasses
- The Cu- and Ga-doped glasses showed the lowest average percent survival
of support cells
[58]
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axonal and myelin damages in the sciatic nerve injury model in rats. Moreover, it has been reported 
that piezoelectric stimulation mediated by boron nitride nanotubes can be applied to improve the 
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Figure 6. (A) Schematic illustration of aminated phosphate glass fibers (PGFs) interfaced with carbon
nanotubes (CNTs) through carboxyl groups to wrap around a poly(L/D-lactic acid) (PLDLA) electrospun
nanofiber mat and fabricate a porous PLDLA cylindrical tube. (B) In vivo implantation of the composite
scaffolds into the proximal and distal stumps of a completely transected sciatic nerve of rats (a)
and histological and immunohistochemical images at 16 weeks post-implantation (b,c) clarifying the
regenerative effect of the scaffolds. Yellow scale bar = 500 µm, black scale bar = 50 µm. Reproduced with
some modifications from ref [79].
6. Borate-Based BGs in Peripheral Nerve Regeneration
The effectiveness of borate BGs for tissue-engineering-based therapies is completely accepted
due to the capability of boron ions to improve cell proliferation, promote angiogenesis, and reduce
inflammation [80–82]. The therapeutic effects of boric acid on peripheral nerve regeneration were
previously studied [83]; the administration of 100 mg/kg of boric acid (four times per day) can reduce
axonal and myelin damages in the sciatic nerve injury model in rats. Moreover, it has been reported
that piezoelectric stimulation mediated by boron nitride nanotubes can be applied to improve the
neurite length of PC12 cells in vitro [84]. Recent studies showed that boron can be easily loaded into
chitosan/collagen hydrogels and promotes key biological functions such as angiogenesis [85].
Borate BGs have recently attracted much attention in the context of soft tissue healing
applications [86]. In vitro experimental data confirmed that borate-based glasses have the ability
to induce stem cells to secrete a series of proteins, including collagen, angiogenin, and VEGF [87].
There is a paucity of studies focused on nerve regeneration, but the early available results are promising
(see Table 1) and justify further investigations. The cytocompatibility of 13-93B3 glass rods and
microfibers (formulation: 53B2O3–20CaO–6Na2O–12K2O–5MgO–4P2O wt.%) with neuronal cells
was documented by Marquardt et al. in 2013 [23]. Similar to silicate- and phosphate-based glasses,
the borate glass scaffolds could increase the percentage of living neurons in vitro. Moreover, the aligned
glass rods supported oriented neurite growth (see Figure 7).
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forms. (B) Microscopic images of embryonic chick dorsal root ganglia (DRG) cells alone (control 
groups a1/a2 and d1/d2) or treated with 13-93 B3 rods (b1/b2 and e1/e2) and microfibers (c1/c2 and 
f1/f2). Note that the images were captured from the cells after 6 days of culture. The culture medium 
was exchanged every other day (transient condition) in the two top rows, while no medium was 
exchanged throughout the experiment (static condition) in the two bottom rows. Scale bar is 100 µm. 
Reproduced with some modifications from ref [23]. 
Several experiments have documented that borate BGs show better mechanical, 
physicochemical, and biological properties after the incorporation of metallic cations (e.g., Ti4+, Cu2+, 
Zn2+, etc.) into their network [88,89]. These dopants typically increase borate glass durability upon 
contact with aqueous fluids. Ion-doped borate BGs have also been developed for potential use in 
peripheral nerve regeneration. Gupta et al. synthesized a series of borate-based BGs containing 
various therapeutic elements, including Ag, Ce, Cu, Fe, Ga, I, Y, and Zn [58]. The results showed that 
Figure 7. (A) SEM micrographs of melt-derived 13-93 B3 borate BGs in rod (a,c) and microfiber (b,d)
forms. (B) Microscopic images of embryonic chick dorsal root ganglia (DRG) cells alone (control
groups a1/a2 and d1/d2) or treated with 13-93 B3 rods (b1/b2 and e1/e2) and microfibers (c1/c2 and
f1/f2). Note that the images were captured from the cells after 6 days of culture. The culture medium
was exchanged every other day (transient condition) in the two top rows, while no medium was
exchanged throughout the experiment (static condition) in the two bottom rows. Scale bar is 100 µm.
Reproduced with some modifications from ref [23].
Several experiments have documented that borate BGs show better mechanical, physicochemical,
and biological properties after the incorporation of metallic cations (e.g., Ti4+, Cu2+, Zn2+, etc.) into
their network [88,89]. These dopants typically increase borate glass durability upon contact with
aqueous fluids. Ion-doped borate BGs have also been developed for potential use in peripheral nerve
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regeneration. Gupta et al. synthesized a series of borate-based BGs containing various therapeutic
elements, including Ag, Ce, Cu, Fe, Ga, I, Y, and Zn [58]. The results showed that Fe-, Ga-, and Zn-doped
BGs could successfully promote the survival and outgrowth of neurons, whereas I-doped BGs were
the most detrimental to neurons.
Prior studies have shown that borate-based BGs can be mixed with polymers to fabricate
electrospun composites as 3D biomimetic structures [90]. In addition, borate glasses have been
successfully mixed with different polymers to prepare injectable hydrogels, which can be utilized in
tissue engineering approaches [91–93]. With respect to neuroregeneration applications, the potential
of composite sheets produced by adding borate-based BGs to PCL was examined in vitro [25].
Three different composites were prepared including 50 wt.% of PCL plus (I) 50 wt.% of 13–93 B3
borate BG, (II) 50 wt.% of 45S5 silicate BG, or (III) 50 wt.% of a blend of (I) and (II) in a 1:1 ratio.
A higher degradation rate was recorded when 13–93B3 borate BG was added to PCL as compared to
the composites containing only 45S5 silicate BGs; however, no adverse effects on neurite extension
were observed after culturing of dorsal root ganglia (DRG) cells isolated from embryonic chicks on all
the composites.
7. Conclusions and Future Perspectives
Although the research field of BGs for neuroregeneration is still in its beginning, these bioactive
materials have shown great promise for the treatment of peripheral nerve and spinal cord injuries.
For this purpose, silicate-, phosphate-, and borate-based BGs have been mainly proposed in the form of
fibers and/or combined with soft polymers for the development of tubular devices to promote axonal
directional growth. At present, BGs have proved suitable to repair small-to-mid peripheral nerve
defects (typically < 2 cm) in animal models, but researchers have not experimented in human patients
yet. Looking at the question posed in the manuscript title, the answer is “yes”—we should be hopeful
about the use of BGs in this new and partially unexplored scenario.
The challenges to be tackled in the future will concern the improvement of tissue regeneration
even for long nerve gaps, as well as investigation of the potential suitability of BG-based biomaterials
in the repair of cranial nerves. The implementation of additive manufacturing technologies (AMTs),
which have already been widely applied in bone tissue engineering [94], will indeed carry significant
added value in this field, too. In fact, AMTs allow for (i) achieving accurate control of the
geometry/porosity of the biomaterial/scaffold/fibrous construct and (ii) combining different biomaterials
(e.g., BGs, polymers) and even cells, which can be printed simultaneously (biofabrication [95]).
Selection of the basic glass composition along with appropriate therapeutic dopants will be key
to postoperative success. Metallic dopants can affect the chemical stability of the glass network and,
hence, the BG reactivity in contact with biological fluids. In this regard, the resorption of the BG-based
conduit should be comparable to that of nerve regeneration. Furthermore, the ion dissolution products
released from BGs can have a direct effect on neural cell activity via pH variations and/or signaling
pathway activation. At present, there is a paucity of studies on this topic; some ions, such as Ga3+ and
Zn2+, seem to have stimulatory effects on neurons [58], but the biomolecular picture is still profoundly
incomplete due to the complexity of interactions among the multiple ions which are typically released
from BGs (not only the dopants but also silicate and phosphate species, Ca2+, and Na+).
The common components of BG structures are generally recognized to be safe for the human body.
Although there have been no specific studies addressing the neuroregeneration scenario, the available
results are quite promising. Lai et al. [96] described the removal pathways of silicon from silicate BG
granules implanted in rabbits over a six-month follow-up period and analyzed the animal brain, heart,
kidney, liver, lung, lymph nodes, spleen, and thymus by using biochemical and histopathological
assays. It was shown that the average excretion rate of silicon was 2.4 mg/day, and all the implanted
silicon was excreted by 19 weeks after implantation. No increased concentration of silicon ions was
detected at the implant site (rabbit paraspinal muscle) or in the internal organs/structures mentioned
above after 24 weeks, and no abnormal histological appearance was detected. It was also reported that
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both silicon derived from implanted silicate BG and boric acid derived from implanted borate BG are
harmlessly excreted from the body through urine in metabolic processes [97,98].
Specific metallic cations with the ability to activate the signaling pathways involved in peripheral
nerve regeneration deserve to be incorporated in BGs and investigated in the near future. Mg2+ ions
were reported to promote the expression of nerve growth factor (NGF) and neurotrophic factor 3 (NTF3)
in Schwann cells [99]. Strontium [100] and gadolinium [101] can activate the Ras/MAPK and PI3K/Akt
signaling pathways, respectively.
It is also worth mentioning that BGs could have a pivotal role in nerve repair due to their
proven pro-angiogenic properties [63], since some studies have recently highlighted the critical role of
angiogenic signaling pathways in improving the quality of peripheral nerve repair [41].
The optimization of the glass-to-polymer ratio in composite biomaterials is also crucial for tailoring
the physical, biological, and mechanical properties of the nerve guidance conduit. The use of electrically
conductive biodegradable polymers [102] as matrixes for the production of BG/polymer composites
also deserves to be investigated; in this way, the electrical insulation properties of BGs would be
somehow compensated.
Another strategy to improve the outcome of nerve guidance conduits could be the incorporation
of chemicals, drugs, or exogenous neurotrophic factors to be released once the biomaterial has been
implanted [103,104]. Such drugs could be introduced into the lumen of hollow resorbable BG fibers
undergoing progressive dissolution after implantation, thus allowing biomolecules to be released.
Mesoporous bioactive glasses (MBGs) [105] could also be considered as versatile platforms for the
controlled release of neural drugs and growth factor. For example, there is abundant literature showing
that MBGs are excellent carriers for ibuprofen, which is commonly used due to its anti-inflammatory
properties [106]; furthermore, this drug was reported to improve nerve functional recovery and increase
the area and thickness of myelinated axons, too [107,108], and it could therefore be encapsulated in
MBG-based drug delivery systems addressing neuroregeneration.
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